Jianke

What Jianke does

Jianke (方舟健客) is a Guangzhou-headquartered, private B2C online pharmacy and digital healthcare services platform operating across mainland China. Its core product is the Fangzhou Jianke Online Pharmacy, which sells prescription drugs, OTC medicines, health supplements, medical devices, and personal care products directly to consumers at prices the company claims are at least 30% below traditional pharmacies. Products are sourced directly from major domestic pharmaceutical manufacturers including Sinopharm (国药集团) and China Resources (华润), with authenticity verifiable against the National Medical Products Administration database. The platform is delivered through the jianke.com website, iOS/Android mobile applications, and WeChat mini-programs (Fangzhou Cloud Medical / 方舟云医), and is fulfilled from a Guangzhou main warehouse with regional distribution centers and temperature-controlled storage via third-party logistics partners (ZTO, YTO, Yunda, J&T, SF Express).

The company complements e-commerce with telemedicine via the Jianke Doctor (健客医生) app, which connects patients with thousands of contracted licensed physicians and pharmacists for online consultations and prescription issuance, integrating video and voice calling through Agora RTC and payment through Alipay and WeChat Pay. It has built an H2H (Hospital-to-Home) ecosystem positioning AI in the management of chronic disease patients (cardiovascular, diabetes, hypertension, liver and kidney conditions), supported by a Health Coin loyalty program (1 coin per RMB 5 spent). The operating group spans subsidiaries in internet hospital services, hospital management, and health management/insurance brokerage, indicating an intent to build a multi-line digital healthcare platform rather than a pure e-commerce pharmacy. Legal operating licenses include a B2C Internet Drug Trading Service Qualification Certificate and an Internet Drug Information Service Operating License from Guangdong Province authorities.

Name

Jianke

Legal name

广州方舟医药有限公司

Website

https://jianke.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Jianke (方舟健客) is a Guangzhou-based private B2C online pharmacy and telemedicine platform selling prescription drugs, OTC medicines, and health products directly to Chinese consumers, complemented by online doctor consultations and a chronic disease management ecosystem.

Ownership category

akta.pro rank

Product category

Online Pharmacy

NAICS

Pharmacies and Drug Retailers (45611), Pharmacies and Drug Retailers (456110)

SIC

Retail-Drug Stores And Proprietary Stores (5912), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA)

akta.pro secondary industry

Health & Pharmacy Omnichannel (CRAFAEAK)

Keywords

• Online pharmacy
• Telemedicine services
• Prescription drug sales
• Healthcare e-commerce
• Chronic disease management

Headquarters

HQ city

Guangzhou

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. B2C Online Pharmacy Sales: Jianke generates revenue primarily through direct-to-consumer online sales of prescription drugs, OTC medicines, health supplements, medical devices, beauty and personal care products. Products are sourced directly from pharmaceutical manufacturers to ensure authenticity, and sold at competitive prices with cost savings passed to consumers.
2. Online Consultation and Telemedicine Services: The platform provides online doctor consultations and pharmacist guidance services, integrating healthcare services with e-commerce. Licensed physicians and pharmacists offer one-on-one health consultations and medication guidance to consumers.
3. Prescription Drug Sales: As a legally licensed B2C internet pharmacy in Guangdong Province, Jianke processes and dispenses prescription drug orders following regulatory requirements, including prescription verification and pharmacist review.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Jianke operates a B2C online pharmacy platform that sells prescription drugs, OTC medicines, health supplements, medical devices, and personal care products directly to individual Chinese consumers at prices reportedly at least 30% below traditional pharmacies. The platform is complemented by online doctor consultation and prescription services through its Jianke Doctor (健客医生) telemedicine offering, enabling a closed-loop healthcare experience where licensed physicians provide guidance, prescriptions are verified, and products are fulfilled from a temperature-controlled Guangzhou warehouse and delivered nationwide via third-party logistics.

Product overview

Jianke operates a multi-platform digital healthcare ecosystem consisting of an online pharmacy (方舟健客网上药店) and a telemedicine service (健客医生). The online pharmacy serves as the core B2C channel offering prescription drugs, OTC medications, medical devices, and health supplements from various pharmaceutical manufacturers, with logistics delivery to customers. The telemedicine platform (健客医生) enables online consultations with licensed doctors, prescription issuance, and health management services, accessible via mobile app and mini-program. These two core products work together to provide an integrated online-to-offline healthcare experience combining medication sales with professional medical guidance.

Differentiator

Problem solved

Functional benefit

Brands

• 健客医生APP: 移动端在线问诊和购药应用，提供图文问诊、电话问诊、处方等服务
• 方舟云医

Products and services

• 方舟健客网上药店 (Fangzhou Jianke Online Pharmacy) A B2C online pharmacy platform (web and mobile app) selling prescription and OTC medications, health supplements, medical devices, and personal care products directly to individual Chinese consumers at manufacturer-direct pricing with doorstep delivery nationwide.
• 健客医生 (Jianke Doctor) A mobile telemedicine application and WeChat mini-program (方舟云医) connecting patients with licensed doctors for text, voice, and video consultations, prescription issuance, and medication guidance, integrated with the online pharmacy for prescription drug fulfillment.

Quantifiable outcome

• Price savings of at least 30% compared to traditional pharmacies through direct manufacturer sourcing

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration15 records

Feature1 record

Partnerships

One partnership is on record.

• Domestic Pharmaceutical Manufacturers (Direct Supply Partnerships)coreTechnology or IntegrationJianke has established strategic direct supply partnerships with numerous large-scale domestic pharmaceutical manufacturers including 国药集团, 华润, and other major pharmaceutical companies. These partnerships ensure direct factory-to-platform sourcing, guaranteeing 100% product authenticity, verifiable through the national drug regulatory authority website.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• JD Health (京东健康): Hong Kong-listed online pharmacy and healthcare services platform spun out of JD.com. Directly comparable B2C prescription/OTC drug retail plus telemedicine, with much larger GMV, capital base, and logistics network anchored on JD's fulfillment infrastructure.
• Alibaba Health (阿里健康): Hong Kong-listed digital health arm of Alibaba, operating one of China's largest online pharmacies (Tmall Medicine) plus telehealth and traceability services. Directly competes with Jianke in B2C pharmacy and pharmaceutical e-commerce.
• Ping An Healthcare and Technology (平安好医生/平安健康): Listed Chinese integrated internet healthcare platform combining online consultations, e-prescriptions, and drug retail. Closely comparable to Jianke's Jianke Doctor plus pharmacy combination, with much larger brand and insurance-group backing.
• 111 Inc. (1药网/壹药网): Nasdaq-listed Chinese online pharmacy and B2B pharmaceutical distribution platform serving both consumers and pharmacies. Direct competitor in B2C drug retail with overlapping manufacturer-sourcing strategy.
• Dingdang Health (叮当健康): Hong Kong-listed quick-commerce online pharmacy in China offering rapid drug delivery and online consultation. Comparable business model centered on OTC/prescription delivery from local fulfillment nodes plus integrated doctor services.

Broad incumbents

• Meituan Instashopping / Meituan Medicine: Meituan's on-demand drug delivery vertical within its broader local services super-app. Competes with Jianke on quick pharmacy delivery in tier-1/2 cities and benefits from Meituan's massive user traffic and rider network.
• Amazon Pharmacy: U.S. online pharmacy operated by Amazon, offering prescription and OTC drug delivery plus clinician consultation. Geographically separate but operates a comparable DTC pharmacy-plus-consultation playbook at much larger scale.
• Walgreens Boots Alliance: Large global pharmacy retailer that has been building digital prescription and online consultation capabilities. Useful as a broad incumbent benchmark for omnichannel pharmacy + clinical services.

Emerging players

• Yixian.com (医线网) / Medlinker (医联): Chinese internet hospital and doctor-platform companies with overlapping chronic disease management and e-prescription focus. Comparable in telehealth and physician network, though typically less pharmacy-retail heavy.

Others

• China Resources Pharmaceutical (华润医药): Major state-affiliated Chinese pharmaceutical manufacturer and distributor that is both a direct-supply partner to Jianke and a participant in online pharmaceutical distribution. Relevant as an ecosystem counterpart and potential partner/competitor in pharma sourcing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries3 records

Funding overview

Funding rounds4 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jianke